A Study to Evaluate EDG-7500 in Caucasian and Japanese Adults

NCT07456059 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Adult Participants

Interventions

DRUG: EDG-7500

Sponsor

Edgewise Therapeutics, Inc.